Medication Case Studies Practice Exam

Instructions: Answer all questions. After submitting, each question will display whether it was correct and a summary of missed items will appear at the bottom.

Case Study 1: Metformin for Type 2 Diabetes

Patient: 55-year-old female with newly diagnosed type 2 diabetes, started on metformin 500 mg PO BID.

Q1. Highlight the assessment findings that are most concerning for a patient on metformin:


Q2. Which order should the nurse question?

Q3. Select all teaching points for metformin:

Q4. Place the following nursing actions in order of priority if the patient develops rapid breathing and confusion:

Q5. Matrix: Indicate if each is a common or serious side effect of metformin:
Side EffectCommonSerious
GI upset (nausea, diarrhea)
Lactic acidosis
Vitamin B12 deficiency

Q6. Which finding requires immediate provider notification?

Case Study 2: Glipizide for Type 2 Diabetes

Patient: 62-year-old male with poorly controlled type 2 diabetes, started on glipizide 5 mg PO daily.

Q7. Highlight the assessment findings that are most concerning for a patient on glipizide:


Q8. Which order should the nurse question?

Q9. Select all teaching points for glipizide:

Q10. Place the following nursing actions in order of priority if the patient develops confusion and diaphoresis:

Q11. Matrix: Indicate if each is a common or serious side effect of glipizide:
Side EffectCommonSerious
Hypoglycemia
Weight gain
Rash

Q12. Which finding requires immediate provider notification?

Case Study 3: Zepbound (GLP-1 Agonist) for Type 2 Diabetes/Obesity

Patient: 48-year-old female with type 2 diabetes and obesity, started on Zepbound (tirzepatide) 2.5 mg SC weekly.

Q13. Highlight the assessment findings that are most concerning for a patient on Zepbound:


Q14. Which order should the nurse question?

Q15. Select all teaching points for Zepbound:

Q16. Place the following nursing actions in order of priority if the patient develops severe abdominal pain and vomiting:

Q17. Matrix: Indicate if each is a common or serious side effect of Zepbound:
Side EffectCommonSerious
Nausea
Pancreatitis
Injection site reaction

Q18. Which finding requires immediate provider notification?

Case Study 4: Jardiance (empagliflozin) for Type 2 Diabetes

Patient: 60-year-old male with type 2 diabetes and heart failure, started on Jardiance 10 mg PO daily.

Q19. Highlight the assessment findings that are most concerning for a patient on Jardiance:


Q20. Which order should the nurse question?

Q21. Select all teaching points for Jardiance:

Q22. Place the following nursing actions in order of priority if the patient develops confusion, abdominal pain, and rapid breathing:

Q23. Matrix: Indicate if each is a common or serious side effect of Jardiance:
Side EffectCommonSerious
Genital yeast infection
Euglycemic diabetic ketoacidosis
Urinary tract infection

Q24. Which finding requires immediate provider notification?

Case Study 5: Lantus (insulin glargine) for Diabetes

Patient: 54-year-old female with type 2 diabetes, started on Lantus 20 units SC at bedtime.

Q25. Highlight the assessment findings that are most concerning for a patient on Lantus:


Q26. Which order should the nurse question?

Q27. Select all teaching points for Lantus:

Q28. Place the following nursing actions in order of priority if the patient develops confusion, diaphoresis, and tremors:

Q29. Matrix: Indicate if each is a common or serious side effect of Lantus:
Side EffectCommonSerious
Hypoglycemia
Injection site reaction
Allergic reaction

Q30. Which finding requires immediate provider notification?

Case Study 6: Humalog (insulin lispro) Sliding Scale

Patient: 45-year-old male with type 2 diabetes, receiving Humalog regular insulin per sliding scale before meals.

Q31. Highlight the assessment findings that are most concerning for a patient on Humalog sliding scale:


Q32. Which order should the nurse question?

Q33. Select all teaching points for Humalog sliding scale:

Q34. Place the following nursing actions in order of priority if the patient develops confusion, sweating, and palpitations:

Q35. Matrix: Indicate if each is a common or serious side effect of Humalog:
Side EffectCommonSerious
Hypoglycemia
Injection site reaction
Hypokalemia

Q36. Which finding requires immediate provider notification?